Literature DB >> 9030543

Signaling of the cardiotrophin-1 receptor. Evidence for a third receptor component.

O Robledo1, M Fourcin, S Chevalier, C Guillet, P Auguste, A Pouplard-Barthelaix, D Pennica, H Gascan.   

Abstract

Cardiotrophin-1 (CT-1) is a recently isolated cytokine belonging to the interleukin-6 cytokine family. In the present study we show that CT-1 activates its receptor expressed at the surface of a human neural cell line by recruiting gp130 and gp190/leukemia inhibitory factor receptor beta, as shown by analyzing their tyrosine phosphorylation level. Neutralizing antibody directed against gp130 and reconstitution experiments performed in the COS-7 cell line demonstrate that gp130-gp190 heterocomplex formation is essential for CT-1 signaling. Analysis of the subsequent activation events revealed that CT-1 induces and utilizes Jak1-, Jak2-, and Tyk2-associated tyrosine kinases, which are in turn relayed by STAT-3 transcription factor. Cross-linking of iodinated CT-1 to the cell surface led to the identification of a third alpha component in addition to gp130 and gp190, with an apparent molecular mass of 80 kDa. Removal of N-linked carbohydrates from the protein backbone of the alpha component resulted in a protein of 45 kDa. Our results provide evidence that the CT-1 receptor is composed of a tripartite complex, a situation similar to the high affinity receptor for ciliary neurotrophic factor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030543     DOI: 10.1074/jbc.272.8.4855

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes.

Authors:  Ursula A White; William C Stewart; Randall L Mynatt; Jacqueline M Stephens
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

3.  Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons.

Authors:  R W Oppenheim; S Wiese; D Prevette; M Armanini; S Wang; L J Houenou; B Holtmann; R Gotz; D Pennica; M Sendtner
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

Review 4.  The role of the leukemia inhibitory factor receptor in neuroprotective signaling.

Authors:  Stephanie M Davis; Keith R Pennypacker
Journal:  Pharmacol Ther       Date:  2017-08-19       Impact factor: 12.310

Review 5.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

6.  Cardiotrophin-1 induces tumor necrosis factor alpha synthesis in human peripheral blood mononuclear cells.

Authors:  Michael Fritzenwanger; Katharina Meusel; Christian Jung; Marcus Franz; Zhenhua Wang; Martin Foerster; Hans-R Figulla
Journal:  Mediators Inflamm       Date:  2010-03-10       Impact factor: 4.711

Review 7.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

Authors:  Peter C Heinrich; Iris Behrmann; Serge Haan; Heike M Hermanns; Gerhard Müller-Newen; Fred Schaper
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

8.  Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing.

Authors:  Darren H Freed; Michael C Moon; Anna M Borowiec; Stephen C Jones; Peter Zahradka; Ian M C Dixon
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

9.  Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model.

Authors:  M Jiménez-González; F Jaques; S Rodríguez; A Porciuncula; R M Principe; G Abizanda; M Iñiguez; J Escalada; J Salvador; F Prósper; P A Halban; M Barajas
Journal:  Diabetologia       Date:  2013-01-29       Impact factor: 10.122

10.  Transregulation of leukemia inhibitory [corrected] factor receptor expression and function by growth factors in neuroblastoma cells.

Authors:  Martha D Port; George S Laszlo; Neil M Nathanson
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.